SETD2 genomic abnormalities are associated with decreased H3K36me3 levels, a distinctive DNA methylation signature6 and chemoresistance in paediatric acute lymphoblastic leukaemia.39 In MLL-rearranged cells from acute leukaemic patients, Setd2 knockdown is implicated in disease initiation and progression by promoting the self-renewal capacity of leukaemic stem cells. The gene discussed is SETD2; the disease is acute lymphoblastic leukemia.